Ablation of Dido3 compromises lineage commitment of stem cells in vitro and during early embryonic development by Fütterer, A et al.
Ablation of Dido3 compromises lineage commitment





4, JC Izpisu ´a-Belmonte
3,5, JL de la Pompa
1,7, P Klatt
1 and C Martı ´nez-A*
,1
The death inducer obliterator (Dido) locus encodes three protein isoforms, of which Dido3 is the largest and most broadly
expressed. Dido3 is a nuclear protein that forms part of the spindle assembly checkpoint (SAC) and is necessary for correct
chromosomesegregationinsomaticandgerm cells.Here wereport thatspeciﬁcablationofDido3 function inmicecauseslethal
developmental defects at the onset of gastrulation. Although these defects are associated with centrosome ampliﬁcation,
spindle malformation and a DNA damage response, we provide evidence that embryonic lethality of the Dido3 mutation cannot
be explained by its impact on chromosome segregation alone. We show that loss of Dido3 expression compromises
differentiationofembryonicstemcellsinvitroandofepiblastcellsinvivo,resultinginearlyembryonicdeathataroundday8.5of
gestation. Close analysis of Dido3 mutant embryoid bodies indicates that ablation of Dido3, rather than producing a generalized
differentiation blockade, delays the onset of lineage commitment at the primitive endoderm speciﬁcation stage. The dual role
of Dido3 in chromosome segregation and stem cell differentiation supports the implication of SAC components in stem cell
fate decisions.
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The death inducer obliterator (Dido) gene has been described
only in higher vertebrates and encodes three splice variants.
Dido1, the smallest of these, was identiﬁed by differential
display PCR in murine bone marrow cells undergoing
apoptosis and its ectopic overexpression was shown to
induce caspase-dependent cell death.
1 Cloning of the Dido
gene yielded two further Dido isoforms, Dido2 and Dido3;
misexpression of these splice variants was linked to myelo-
dysplastic syndrome/myeloproliferative disease.
2 The ﬁnding
that N-terminal truncation of Dido3 (Dido3DNT) provokes
increased incidence of hematological myeloid neoplasms in
the adult mouse further supports a role for this gene in tumor
suppression.
2
Subsequent studies have focused on Dido3, the largest and
mostbroadlyexpressedisoform.Dido3isanuclearproteinthat
recognizes trimethylated histone H3 lysine 4 through its N-
terminal plant homeodomain domain,
3 and interacts with
centrosomes and the synaptonemal complex in somatic
4 and
germ cells,
3 respectively. Cells expressing an N-terminally
truncated and partially inactive Dido3 form that lacks the
sequence motifs needed for association with histones
(Dido3DNT)showcentrosomeampliﬁcation,spindlemalformation
and chromosome segregation defects.
4 Dido3DNT cells
bypass the spindle assembly checkpoint (SAC) through
unscheduled degradation of BubR1, which renders them
permissive to aneuploidy, chromosomal instability and DNA
damage.
4,5 A limitation for evaluation of speciﬁc Dido3
function in the Dido3DNT mouse mutant is that elimination
of the sequence encoding the Dido gene N-terminus in the
germline also affects Dido1 and Dido2 isoforms. Moreover,
elimination of this N-terminal sequence inactivates Dido3 only
partially, leaving intact a number of functional domains
thought to be involved in Dido3 interaction with DNA,
chromatin and other proteins.
6,7 To further explore the role
of Dido3, we speciﬁcally ablated Dido3 expression in the
mouse and established Dido3 mutant embryonic stem (ES)
cells. We show that loss of Dido3 expression is embryonic
lethal and compromises lineage commitment of ES cells
in vitro and of epiblast cells at the onset of gastrulation in vivo.
Results
Ablation of Dido3 is embryonic lethal. We generated a
Dido3-speciﬁc mouse mutant using red ﬂuorescence protein
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www.nature.com/cdd(RFP) to replace the only Dido3-speciﬁc exon in the Dido
locus, which eliminates almost 50% of the Dido3 C-terminal
sequence, leaving intact the functional domains in Dido2
(Dido3DCT-RFP, Figure 1a; Supplementary Figure 1). The
mutant Dido3 allele was transmitted to the germline
and yielded macroscopically normal mice heterozygous for
full-length Dido3; we were nonetheless unable to generate
viable homozygous Dido3DCT-RFP mice by intercrossing
heterozygotes. Analysis of blastocyst explants and embryos
from Dido3 heterozygote intercrosses showed Dido3 mutant
embryos at the expected Mendelian frequency up to day 8.5
post-coitum (E8.5), none of which survived beyond this time
(Figure 1b). Absence of Dido3 expression in the developing
embryo (Supplementary Figure 2) was associated with gross
morphological abnormalities that became overt by E7.5 and
particularly affected the embryonic ectoderm (Figure 1c).
Histological analysis showed that the trophoblast and
extraembryonic regions were less affected than the epiblast
by Dido3 ablation (Figure 1d). In these embryos, we
assessed the ablation of Dido3 and expression of the
Dido3DCT-RFP mutant by western blot (Figure 1e); we
also used reverse transcriptase (RT)-PCR to verify normal
expression of Dido1 and Dido2, ablation of Dido3 and
expression of the Dido3DCT-RFP mutant (Figure 1f).
Although we cannot rule out that the Dido3DCT-RFP allele
might cause a subtle neomorphic phenotype, these data
support the interpretation that elimination of the C-terminal
portion of Dido3 compromises Dido3 function, resulting in
early embryonic lethality.
Abrogation of Dido3 causes chromosome segregation
defects and provokes a DNA damage response. Previous
work showed that N-terminal truncation of Dido3 (Dido3DNT,
Figure 1a) impairs the SAC machinery, provoking
centrosome ampliﬁcation, spindle malformation and
aneuploidy.
3,4 In cells obtained from Dido3DCT-RFP
compared with wild type (Wt) embryos at E7.5, we
observed an increase in cells with less than one or more
than two centrosomes per cell, resulting in a moderate but
signiﬁcant increase in cells with an abnormal centrosome
number (Figure 2b).
Chromosome segregation defects are a potential source of
DNA damage and chromosomal instability.
8 In Dido3DCT-
RFP E7.5 embryos, we detected cells that stained positive for
phosphorylated g-H2AX, a surrogate marker for DNA damage
(Figure 2c, top). DNA damage in the Dido3 mutants was
paralleled by an apoptotic response, indicated by accumula-
tion of terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL)-positive cells (Figure 2c, bottom). Centro-
some dysfunction is also linked to a p53/p21-dependent block
of cell cycle progression.
9 We found that proliferation rates,
measured as bromodeoxyuridine (BrdU) incorporation into
embryonic tissues, were lower in Dido3DCT-RFP embryos
than in Wt controls (Figure 2d). Both apoptosis and growth
arrest were observed in the epiblast region, and affected
extraembryonic tissue only to a minor extent (Figures 2c and d).
Impaired proliferation in Dido3-deﬁcient embryos was accom-
panied by a signiﬁcant increase in p21 and p16 expression
(Figure 2e), as well as by hypophosphorylation of the
retinoblastoma protein (Figure 2f). These molecular changes
are reminiscent of a canonical senescence response to DNA
damage, which requires activation of the p53/p21 and p16/
retinoblastoma (Rb) pathways.
10 Nonetheless, when we
crossed the Dido3DCT mutation onto a p53-deﬁcient back-
ground, a genetic manipulation intended to render Dido3
mutants resistant to p53-dependent apoptosis and growth
arrest, we were unable to rescue the lethal phenotype of
Dido3DCT-RFP mice (Supplementary Table 1).
Ablation of Dido3 disrupts epiblast cell differentiation. As
shown above, accumulation of apoptotic and growth-arrested
epiblast cells in Dido3DCT-RFP mutants at E7.5 coincides with
the onset of developmental defects in the embryonic ectoderm.
Epiblast integrity is critical to early embryonic development, as
this region contains pluripotent cells from which all three
embryo layers are derived during gastrulation.
11 Epiblast cell
differentiation is triggered by repression of transcription factors
necessary for establishing and maintaining stem cell
pluripotency, such as Oct4.
12 We found that by E7.5, Oct4
was no longer detectable in Wt embryos, concurring with the
literature,
13 whereas Dido3 mutant embryos showed persistent
Oct4 expression in the epiblast (Figure 3a). Brachyury, a
speciﬁc marker for nascent mesoderm,
14 was clearly
expressed in Wt embryos but virtually absent from Dido3
mutants, whereas the diploid trophoblast marker Mash-2
15 was
observed in both embryo types (Figure 3b). Dido3DCT-RFP
embryos also showed altered expression of mRNA encoding
the mesodermal marker proteins Brachyury and Twist, the
visceral endoderm marker HNF4 and the anterior patterning
markers Nodal and Cerberus1 (Figure 3c). These ﬁndings
indicate that Dido3 is essential for an early stage of
embryogenesis related to lineage commitment at the onset of
epiblast cell differentiation.
Dido3 is dispensable for ES cell self-renewal and
pluripotency. The embryonic post-implantation phase (up
to E6.5) is characterized by rapid proliferation of stem cells
derived from the inner cell mass. By the beginning of
gastrulation (E6.5), stem cell proliferation ceases and
differentiation into the three germ layers is initiated.
16 As
this early stage of stem cell differentiation was associated
with the onset of lethal developmental defects in Dido3
mutants, we established ES cell lines from blastocyst
outgrowths obtained from intercrosses of Dido3DCT-RFP
heterozygotes and analyzed their capacity to proliferate and
differentiate in vitro. As predicted by the presence of cells
with chromosome segregation defects in Dido3DCT-RFP
embryos, Dido3DCT-RFP ES cells were aneuploid
(Figure 4a), with centrosome ampliﬁcation and multipolar
spindles in B10% of cells (Figure 4b). Despite these
chromosome segregation defects, the proliferative capacity
of undifferentiated Dido3 mutant ES cells was unaffected
(Figure 4c, top), indicating that Dido3 is dispensable for ES
cell self-renewal. To explore the impact of Dido3 abrogation
on ES cell differentiation, we used the hanging drop method
to aggregate ES cells into embryonic bodies (EBs) and
induced their further differentiation by propagation in
gelatinized cell culture dishes in the absence of leukemia
inhibitory factor (LIF). In these conditions, differentiation of
Dido3DCT-RFP ES cells was impaired and they underwent
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Cell Death and DifferentiationFigure 1 Ablation of Dido3 is embryonic lethal. (a) The three isoforms encoded by the Dido locus (Dido1, Dido2 and Dido3), as well as the two Dido loss-of-function
mutants studied so far (DidoDNT, previously published;
2 Dido3DCT-RFP, this study). Common and isoform-speciﬁc portions of the Dido proteins are indicated (light gray,
regions common to all three Dido isoforms; dark gray, regions common to Dido2 and Dido3; black, Dido3-speciﬁc regions; hatching, short isoform-speciﬁc C-terminal
fragments). The location of the in-frame RFP cassette in the Dido3DCT-RFPmutant is indicated(RFP). Numbers denote amino acid position, countedfrom the N-terminus of
the three Dido isoforms. Abbreviations below indicate the approximate positions of Dido functional domains (NLS, nuclear localization signal; PHD, plant homeodomain;
TFIIS2M, transcription factor S domain II module; SPOC, Spen paralog and ortholog C-terminal domain; PRO, proline-rich domain; ALA, alanine-rich domain; CC, coiled-coil
domain; ARG, arginine-rich domain). (b) Ablation of Dido3 is embryonic lethal. Embryos from intercrosses of Dido3DCT-RFP heterozygous mice were genotyped by PCR at
different gestational stages. Embryonic days (E) are days post-coitum. Wt/Wt, Wt for Dido3; Wt/DCT, heterozygous for Dido3DCT-RFP; DCT/DCT, homozygous for
Dido3DCT-RFP; ND, not determined due to embryo resorption. An asterisk indicates the presence of overt morphological alterations. (c) Comparison of whole Wt/Wt and
DCT/DCT embryos at E7.5. Regions corresponding to the trophoblast (tr), extraembryonic ectoderm (exe) and embryonic ectoderm (ee) are indicated. (d) Histological
comparison of whole Wt/Wt and DCT/DCT embryos. HE-stained sections of Wt/Wt and DCT/DCT embryos at E7.5, E8.0 and E8.5 are shown at indicated magniﬁcations.
Embryonicregionscorrespondtotr, exeand ee,aswell ashead (h) and somites(s). (e)LysatesofWt/Wt andDCT/DCTembryosatE7.5wereanalyzedbywestern blot withan
anti-Dido3 C-terminus-speciﬁc antibody.b-actinwas usedasloading control(left). The anti-commonamino-terminal segmentantibody totheN-terminal portion ofDido, common
to all Dido isoforms,
3 was used to assay lysates of Wt/Wt, Wt/DCT and DCT/DCT embryos at E7.5 for expression of Dido3 and Dido3DCT-RFP (right). (f) RT-PCR was used to
monitor Wt/Wt and DCT/DCT E7.5 embryos for expression of the splice variants Dido1, Dido2, Dido3 (1, 2 and 3) and Dido3DCT-RFP (DCT) using b-actin as control (C)
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Cell Death and DifferentiationFigure 2 Abrogation of Dido3 causes chromosome segregation defects and provokes a DNA damage response. (a) Centrosome number was determined by staining for
g-tubulin and centrin (red dots) on cytospin slides of disaggregated Wt/Wt and DCT/DCT embryos at E7.5. Nuclei were counterstained with 40,6-diamidino-2-phenylindole
(DAPI)(bluebackground).(b)Theincidenceofcentrosomeanomaliesintheseembryoswasquantiﬁedasthepresenceofmorethantwoorlessthanonecentrosomepercell
as a percentage of total cells analyzed. Data were obtained from four mice per genotype and analyzed for statistically signiﬁcant differences using the Fisher exact test.
(c) Sections from Wt/Wt and DCT/DCT embryos at E7.5 were assayed for DNA damage (cells positive for phosphorylated g-H2AX, brown dots) and apoptosis (TUNEL-
positive cells, green dots). Arrowheads indicate areas of positive staining in the epiblast. Nuclei were DAPI-counterstained (blue). DAPI and TUNEL staining were performed
on the same sections of a parafﬁn-embedded embryo, whereas g-H2AX detection was performed in a different embryo. (d) Sections from Wt/Wt and DCT/DCT embryos at
E7.5 were assayed for proliferation by monitoring BrdU incorporation 1h post-BrdU injection into pregnant mice, followed by ﬂuorescein isothiocyanate-anti-BrdU staining
(green).NucleiwereDAPI stained (blue).Selectedareasof theepiblast(indicatedby numbers1 and3 inWt/Wtand DCT/DCT embryos,respectively) andtrophoblast(2 and
4 in Wt/Wt and DCT/DCT embryos, respectively) are shown at higher magniﬁcation. (e) p21 and p16 expression levels were assayed by RT-PCR in tissue homogenates of
Wt/Wt and DCT/DCT embryos at E7.5. Data show mean±S.E.M. from three mice per genotype, each in triplicate and normalized to 18S mRNA expression. Statistical
signiﬁcance was calculated using Student’s t-test. (f) Representative western blot analysis of Wt/Wt and DCT/DCT embryo lysates at E7.5 for the active growth-promoting
form of retinoblastoma protein phosphorylated at serines 807/811 (pRb), using b-actin as loading control
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Cell Death and Differentiationgrowth arrest and apoptosis (Figure 4c, bottom), which raises
the question whether loss of Dido3 expression abrogates ES
cell pluripotency. Teratoma assays are widely used to
demonstrate the differentiation potential of pluripotent ES
cells.
17 We found that subcutaneous injection of Dido3DCT-
RFP ES cells into immunodeﬁcient mice yielded teratomas
(Figure 4d), although at a signiﬁcantly lower frequency than
Wt ES cells (Figure 4e). Histological analysis of Dido3 mutant
teratomas nonetheless conﬁrmed that Dido3DCT-RFP ES
cells retained the capacity of pluripotent ES cells to form all
three germ layers after ectopic transplant (Figure 4f). These
results suggest that abrogation of Dido3 expression, although it
impairs ES cell differentiation in vitro, does not produce a
generalized blockade of lineage commitment in vivo.
Abrogation of Dido3 compromises ES cell lineage
commitment. Aggregation of ES cells into EB and their
further differentiation into all three germ layers is considered
to be an in vitro model that recapitulates essential aspects of
early embryonic development.
18 Following aggregation, Wt
ES cells formed EB; when they were maintained in
suspension culture for several days in the absence of LIF,
they continued to differentiate, as evidenced by characteristic
changes in cell morphology and loss of alkaline phosphatase
(AP) staining (Figure 5a, top). Dido3DCT-RFP ES cells
retained the capacity to form EB, but did not differentiate
further in these conditions (Figure 5a, bottom), determined by
persistent AP staining and absence of morphological
changes as well as by expression of stem cell genetic
markers.
There is evidence that the activity of a set of transcriptional
regulators, including Oct4, Nanog and Sox2, is sufﬁcient to
confer pluripotency and to regulate stem cell self-renewal and
differentiation.
19 ES cell differentiation is dependent on the
progressive downregulation of these transcriptional regula-
tors.
12 Oct4, Nanog and Sox2 protein expression in Wt ES
cells began to decline 4 to 6 days after EB formation and LIF
withdrawal, and was barely detectable by day 14 (Figure 5b,
left). In Dido3 mutant EB, Oct4 repression was abrogated and
downregulation of Sox2 and Nanog was delayed (Figure 5b,
right), conﬁrming that Dido3 is necessary for LIF-dependent
ES cell differentiation in vitro.
Although LIF is a key factor in maintaining ES cells in an
undifferentiated state, LIF removal is not essential for initial
speciﬁcation of the primitive endoderm induced by ES cell
aggregation into EB.
20 Aggregation-induced ES cell differentia-
tion in vitro begins with the formation of a primitive endoderm
layer on the surface of the ES cell aggregate, which is GATA-4-
dependent
21 and a prerequisite for basement membrane
formation and subsequent separation of the primitive endoderm
fromtheinnerEBcellmass.
22Afteraggregationandsubsequent
culture without LIF, Wt EB began to form a primitive, GATA-4-
expressing endoderm layer; primitive endoderm formation in Wt
EB was completed by day 2–3, followed by the onset of ES cell
differentiation (Figure 6a). In these conditions, primitive
endoderm formation was delayed in Dido3 mutant EB, as
evidenced by their morphology and the delayed onset of GATA-
4 expression (Figure 6a). We noted a comparable delay in
primitive endoderm formation in Dido3DCT-RFP EB after
aggregation in the presence of LIF; after 5 days, Dido3 mutant
ES cells completed formation of a GATA-4-positive primitive
endoderm layer (Figure 6b). These data indicate that loss of
Dido3 expression delays primitive endoderm speciﬁcation
independent of LIF signaling.
Figure 3 Lackof Dido3 expression disrupts epiblastcell differentiation. (a) Wholeembryos fromWt/Wt andDCT/DCT at E7.5 were examinedby immunoﬂuorescencefor
expression of Oct4, an undifferentiated pluripotent cell marker. Diffuse green staining in the Wt embryo indicates background (lack of Oct4 expression). Arrowheads mark
regions with persistent Oct4 expression in the epiblast of a representative DCT/DCT embryo. Embryonic regions correspond to tr, exe and ee. (b) In situ hybridization was
used to assess expression of Brachyuryand Mash2, markersspeciﬁc for nascentmesoderm and diploid trophoblastcells, respectively,in sections from Wt/Wt andDCT/DCT
embryos at E7.5. Arrowheads indicate regions that stain positive for these markers. (c) RT-PCR analysis was used to quantify expression of the mesodermal markers Twist
and Brachyury, the visceral endoderm marker HNF4 and the anterior patterning gene products Nodal and Cerberus1 (Cer1). Data are mean values±S.E.M., n¼3
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Cell Death and DifferentiationFigure 4 Dido3 is dispensable for ES cell self-renewal and pluripotency. (a) Colcemid-arrested metaphase spreads from Wt/Wt and DCT/DCT ES cells were karyotyped.
Cells with more or less than 40 chromosomes (2N) were scored as aneuploid. The number of aneuploid metaphases relative to the total number of metaphases analyzed is
shownaboveeachbar.TheFisherexacttest wasusedfor statisticalcomparison.(b)Tworepresentativeexamplesforthepresence ofmultipolarspindles(g-tubulin;reddots)
in interphase and mitotic nuclei of DCT/DCT ES cells. (c) Cell cycle proﬁles of propidium iodide (Pi)-stained Wt/Wt and DCT/DCT ES cells maintained as undifferentiated ES
cells (top) or differentiated in vitro by aggregation into hanging drops and subsequent adhesion of the EB obtained to gelatinized cell culture dishes (bottom). Apoptotic cells
(Ap)andcellploidy(1N,2Nand4N)areindicated;theinsetshowsrepresentativephotomicrographsforWt/WtandDCT/DCTEB.TheproliferativecapacityofEScellsandEB
was assayed by BrdU incorporation and quantiﬁed on scatter-plots of BrdU versus Pi signal. The percentage of proliferating cells is indicated. (d) Pluripotency of Wt/Wt and
DCT/DCTEScellswasassessedbyectopictransplantintoimmunodeﬁcientrecombinationactivatinggene2knockoutmice(10
6cells/injection).Representativeexamplesare
shownof teratomaformationafterinjectionofWt/Wtand DCT/DCT EScells.(e) Bargraphquantiﬁestheefﬁciencyof teratomaformationfrom Wt/WtandDCT/DCT EScells.
Thenumberofinjectionsthatyieldedovertteratomaswithin6weeksrelativetototalnumberofinjectionsisgivenaboveeachbar.TheFisherexacttestwasusedforstatistical
comparisons. (f) Mice were killed at 6 weeks post-injection to isolate teratomas. Histology of HE-stained DCT/DCT teratoma sections conﬁrms that DCT/DCT ES cells retain
the capacity to differentiate into all three germ layers (endoderm, mesoderm, ectoderm)
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Cell Death and DifferentiationWe performed various experiments to study whether, once
primitive endoderm formation was complete, Dido3DCT-RFP
EB were able to exit from the pluripotent state and to
differentiate. In a ﬁrst assay, we aggregated Dido3DCT-RFP
ES cells into EB, triggered primitive endoderm formation for 5
days with LIF (see Figure 6a) and subsequently induced
differentiation by LIF withdrawal; Dido3DCT-RFP EB ap-
peared able to differentiate (Figure 7a). We also co-cultured
Wt and mutant ES cells to establish in vitro chimeras. In these
conditions, the kinetics of primitive endoderm formation
resembled that of the Wt cells and differentiation was similar
to that in Wt EB, as detected by the expression of speciﬁc
genes (not shown). Finally, as defects in primitive endoderm
formation in GATA-4-deﬁcient ES cells
21 can be rescued by
activation of the retinoic acid signaling pathway,
23 we tested
this system and found that retinoic acid restored Dido3DCT-
RFP EB ability to differentiate, indicated by morphological
changes similar to those of Wt cells (not shown).
To evaluate the impact of experimental conditions that
delayed endoderm speciﬁcation in Dido3 mutant EB, we
screened EB for markers representative of undifferentiated
ES cells and of all three germ layers. Compared with Wt EB,
Dido3 mutant EB cultured for 10 days without LIF showed an
overallpersistenceofgenesassociatedtoundifferentiatedES
cells (Figure 7b, red bars); this included a three to ﬁvefold
increase in pluripotency determinants such as Oct4, Nanog
and Foxd3, as well as in genes that prevent cultured ES cell
differentiation such as Nodal, Cripto7 and Gdf3.
24,25 Expres-
sion of endoderm, mesoderm and ectoderm markers, all
indicative of differentiation, was decreased (Figure 7b, red
bars). The extraembryonic endoderm genes GATA-4 and
GATA-6, necessary for endoderm differentiation,
21,23 were
expressed at 10- to 20-fold lower levels in Dido3 mutants than
in Wt EB (Figure 7b, red bars). There was an eightfold
decrease in expression of the endoderm marker laminin B1
(Lamb1), a protein associated with deposition of subendo-
dermal basement membrane by primitive endoderm cells and
necessary for subsequent germ layer formation
26 (Figure 7b,
red bars). These data conﬁrm that Dido3 ablation impairs
stem cell differentiation already at the onset of primitive
endoderm formation. Conditions that allow completion of
endodermformationinDido3DCT-RFP EBbeforeinductionof
differentiation (5 days preliminary culture with LIF) partially
restored the Wt expression pattern; this included down-
regulation of pluripotency-associated genes (Oct4, Sox2) and
induction of genes required for differentiation of endoderm
(GATA-4/6, Lamb1), mesoderm (Flt1, Cdh5/VE-cadherin)
and ectoderm (Syp) (Figure 7b, blue bars). When retinoic
acid was used to bypass delayed primitive endoderm
formation in Dido3DCT-RFP EB, suppression of pluripotency
genesandrestoredexpressionofgenesrepresentingallthree
germ layers was even more pronounced (Figure 7b, green
bars). These ﬁndings show that impaired differentiation of
Dido3DCT-RFP ES cells can be overcome in vitro in
conditions that allow prior completion of primitive endoderm
speciﬁcation.
The role of Dido3 in ES cell differentiation can be
separated from its function in chromosome
segregation. Partial inactivation of Dido gene products, by
Figure5 Dido3isnecessaryforEScelldifferentiationinvitro.Wt/WtandDCT/DCTEScellswereculturedwithLIFtoimpededifferentiation(ES),orwereaggregatedinto
EB and maintained without LIF for the indicated time in untreated bacterial plates to induce differentiation. (a) AP staining was used as an indicator of undifferentiated and
pluripotentstemcells.PhotomicrographsshowrepresentativeresultsforEScellsandEBat  20and  10magniﬁcation,respectively.(b)Westernblotanalysiswasusedto
assay expression of proteins considered pluripotency markers (Oct4, Nanog, Sox2) in ES cells and EB; b-actin was used as a loading control
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Cell Death and Differentiationtruncation of the N-terminal domain common to the three
Dido isoforms (Dido3DNT), impairs the SAC machinery and
provokes centrosome ampliﬁcation, spindle malformation,
aneuploidy and DNA damage.
4,5 The extensive Dido3
truncation in the Dido3DCT-RFP mutant might exacerbate
the effects observed after partial Dido inactivation in the
Dido3DNT mutant, which could account for impaired stem
cell differentiation, developmental defects and early
embryonic lethality in Dido3DCT-RFP mice. Chromosome
imbalance in Dido3DCT-RFP mutants is comparable to that
in Dido3DNT mice, although there is no appreciable impact
on development in the latter.
4 Mitotic defects thus do not
Figure 6 Ablation of Dido3 delays aggregation-induced primitive endoderm formation. Photomicrographs (gray-tone images) show representative EB obtainedb y
aggregation of Wt/Wt and DCT/DCT ES cells and subsequent propagation in the absence (w/o) (a) or presence (with) (b) of LIF for the time indicated. Primitive endoderm
formation was monitored by immunoﬂuorescence using antibody to the endoderm marker GATA-4 (bright red signal)
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Cell Death and Differentiationappear to account fully for the lethal phenotype of the
Dido3DCT-RFP mutation. To test this hypothesis, we
generated double mutants by crossing heterozygous
Dido3DCT-RFP with heterozygous Dido3DNT mice;
although Dido3DCT-RFP/Dido3DNT mice were not born at
the expected Mendelian frequency, we obtained viable Dido3
double mutants (Figure 8a). Karyotype analysis of
Dido3DCT-RFP/Dido3DNT and Wt embryo primary
ﬁbroblasts showed an Btwofold increase in aneuploid cells
(58.7±6.5% versus 28.7±3.7%, n¼2), accompanied by an
increase in structural chromosomal aberrations and
Figure 7 Impaired differentiation of Dido3 mutant ES cells can be rescued
in vitro.( a) Photomicrographs of representative EB obtained by aggregation of Wt/
Wt and DCT/DCT ES cells and subsequent propagation with LIF for 5 days before
inducing differentiation by LIF withdrawal for a further 9 days. (b) Quantitative
RT-PCR was used to determine the expression of selected markers for
undifferentiated ES cells, endoderm, mesoderm and ectoderm in differentiating
EB. Differentiation was induced by aggregation of ES into EB and maintenance of
EB for a further 10 days in suspension on untreated bacterial plates in medium
without LIF (red bars) and supplemented with 0.5mM retinoic acid (green bars).
Alternatively, differentiation was induced by aggregation of ES cells into EB
and subsequent maintenance as in a (blue bars). Data show mean values for
two experiments±S.E.M. and represent expression of the markers analyzed in
DCT/DCT EB relative to Wt/Wt EB
Figure8 TheroleofDido3inEScelldifferentiationcanbedistinguishedfromits
function in chromosome segregation. (a) Dido3DCT-RFP embryonic lethality was
rescued by intercrossing heterozygous Wt/DCT with heterozygous Wt/DNT mice to
obtain a double mutant (DCT/DNT). Total number of viable pups is shown for each
genotype;thecontributionofeachgenotyperelativetothetotalnumberofmiceborn
is indicated in parentheses. (b) Full-length Dido3 (Dido3) and the N-terminal Dido3
truncation mutant (Dido3DNT) were overexpressed in DCT/DCT ES cells.
Centrosome number was determined by staining for g-tubulin. Cells were scored
as positive for centrosome anomalies when more than two or less than one
centrosome per cell were detected. The number of cells with centrosome
ampliﬁcation as a percentage of the total number of cells analyzed is shown above
each bar. The Fisher exact test was used for statistical comparison with Wt/Wt ES
cells. (c) Full-length Dido3 and Dido3DNT were overexpressed in DCT/DCT ES
cells.DifferentiationwasinducedbyaggregationintoEBandmaintenanceofEBfor
a further 10 days without LIF. Quantitative RT-PCR was used to determine the
expression of selected markers for undifferentiated ES cells, endoderm, mesoderm
and ectoderm in DCT/DCT EB overexpressing full-length Dido3 (red bars) and
Dido3DNT (blue bars). Data show mean values of two experiments±S.E.M. and
represent expression of the markers analyzed in DCT/DCT EB transfected with
Dido3 and Dido3DNT, relative to Wt/Wt EB
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Cell Death and Differentiationpremature sister chromatid exchange (not shown). In
in vitro experiments, overexpression of Dido3DNT in
Dido3DCT-RFP ES cells did not rescue centrosome
ampliﬁcation (Figure 8b), but restored the capacity of these
cells to express markers representative of all three germ
layers (Figure 8c). At difference, overexpression of full-length
Dido3 in Dido3DCT-RFP ES cells reconstituted both normal
centrosome numbers and the ability of cells to differentiate in
the absence of LIF. The ﬁnding that Dido3DNT rescues
speciﬁc Dido3DCT-RFP defects indicates a function of
full-length Dido3 in stem cell differentiation that can be
segregated from its known role in the SAC.
Discussion
Previous characterization of a mouse model bearing an
N-terminal Dido3 truncation mutant (Dido3DNT)
2 showed an
essential role for Dido3 in SAC regulation and surveillance.
4
As the hypomorphic Dido3DNT mutant conserves functional
domains related to cell signaling and transcriptional regula-
tion,
6,7 we speculate that Dido3 has biologically relevant
functions beyond its established role in chromosome segre-
gation. By analyzing mice with a Dido3-speciﬁc mutation that
eliminates almost 50% of the Dido3 C-terminal sequence, we
showthatDido3isessentialforearlyembryonicdevelopment.
In accordance with ﬁndings in somatic
4 and germ
3 cells, we
observed that absence of full-length Dido3 is associated with
multipolar spindles, centrosomal ampliﬁcation and aneu-
ploidy. We show that these chromosome anomalies provoke
DNA damage, apoptosis and growth arrest during ES cell
differentiation in vitro and during early embryonic develop-
ment in vivo. These ﬁndings ﬁt well with reports on the
phenotype of mice deﬁcient for other regulators of spindle
assembly and mitosis, such as BubR1, Bub3, Rae1 and
Mad2.
27 Although SAC disruption is generally associated with
embryonic lethality,
27 we provide evidence that abrogation of
Dido3 expression disrupts early embryonic development
through mechanisms different from those implicated in
chromosome segregation. Genetic ablation of p53 failed to
render Dido3DCT mutants resistant to p53-dependent apop-
tosis and growth arrest. Moreover, genetic rescue experi-
ments showed that Dido3DNT was unable to reduce
chromosome segregation defects in Dido3DCT-RFP cells,
but rescued embryonic lethality of the Dido3DCT mutation.
We further show that differentiation is impaired in Dido3DCT-
RFP ES cells and that Dido3DNT overexpression rescues this
defect. As Dido3 is ubiquitously expressed in the developing
embryo, we cannot rule out that abrogation of Dido3 affects
regions other than the epiblast. Nonetheless, the observation
that onset of embryonic lethality in Dido3DCT-RFP mice
coincides with failure of epiblast cell differentiation supports
our conclusion that Dido3 expression is crucial in stem cell
differentiation.
Genome-widescreenshaveidentiﬁedanumberofpotential
regulators of stem cell function, including genes with
established roles in transcriptional regulation, cell growth
and differentiation, but also others whose function is largely
unknown or remains to be validated, such as the Dido
gene.
28–33 Here we use the model of ES cell aggregation into
EB and subsequent LIF withdrawal to show that Dido3DCT-
RFP ES cells do not differentiate correctly. Loss of Dido3
expression nonetheless does not produce a generalized
differentiation blockade, corroborated by the observation that
Dido3DCT-RFP ES cells differentiate in response to retinoic
acid and form all three germ layers in the teratoma assay. The
Dido3 mutant ES cell phenotype is reminiscent of GATA-4-
deﬁcient ES cells, a model for disrupted endoderm lineage
commitment.
21,34 Like Dido3 mutants, GATA-4-deﬁcient ES
cells fail to differentiate after aggregation and LIF withdrawal,
as shown by sustained expression of Oct4 and other
undifferentiated stem cell markers; their ability to differentiate
can be restored by retinoic acid.
21,23,34 GATA-4 expression is
needed in certain signaling pathways to detect cell aggrega-
tion and cell positioning, and thus induce differentiation; this
requirement can be bypassed by retinoic acid.
23 Dido3DCT-
RFP ES cells recover their capacity to differentiate in
response to LIF withdrawal when the previous aggregation
period is prolonged and the mutants complete primitive
endoderm formation. This suggests that, among its other
possible effects, loss of Dido3 expression impairs ES cell
differentiation by delaying primitive endoderm speciﬁcation.
Weproposethatthisdelayedonsetofstemcelldifferentiation,
althoughitcanbebypassedincertainexperimentalconditions
in vitro (retinoic acid treatment, prolonged aggregation) and
in vivo (teratoma assay), explains impaired epiblast differ-
entiation and contributes to embryonic lethality in the
Dido3DCT-RFP mouse model.
How lack of Dido3 expression delays primitive endoderm
formation remains to be determined. The initial defect could
be caused by the delayed downregulation of stemness-
associated transcription factors (particularly in the case of
Oct4), by delayed upregulation of genes needed to form
primitive endoderm, or by a combination of both. We
distinguished the role of full-length Dido in chromosome
segregation from the speciﬁc function of the Dido3 C terminus
in stem cell differentiation; however, this does not rule out a
functional link between the two processes. A recent study
shows that loss of expression of BubR1, a key SAC
component, compromises the differentiation potential of adult
stem cells.
35 Correct spindle positioning ensures proper
chromosome inheritance to daughter cells during each cell
division. Deﬁnition of the cleavage plane by correct spindle
pole positioning and close surveillance of this process by the
SAC
36 are the basis of asymmetric stem cell division and
differentiation.
37,38 Adhesion molecules are thought to enable
the fundamental stem cell property of switching between
asymmetrical and symmetrical division by regulating centro-
some positioning and spindle angle in response to cell–cell
contacts between the stem cell and cells in its niche.
39 The
role of Dido3 in the SAC,
4 which senses and signals
centrosome position and spindle tension,
36 and its implication
in an early cell–cell contact-induced ES cell differentiation
step,renderDido3anappropriatecandidateforfuturestudyof
proteins that couple centrosome orientation to stem cell fate
decisions.
Materials and Methods
Mice and ES cells. Dido3 mutant mice were generated by targeting the only
Dido3-speciﬁc exon (exon 16) of the Dido locus. Details of gene targeting strategy
are available online as Supplementary Information (Supplementary Figure 1). Mice
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Cell Death and Differentiationwere handled in accordance with national and European Union legislation, with
approval of the Committee for Ethics in Animal Experimentation of the Centro
Nacional de Biotecnologı ´a (CNB/CSIC).
To establish ES cell lines, blastocysts were ﬂushed from the uterus of pregnant
female mice at 3.5 days post-coitum and immediately plated in IVF dishes on
irradiated mouse embryonic ﬁbroblasts (MEF) in ES cell medium. Inner cell mass
outgrowths were picked after 5–7 days, fragmented following limited digestion in a
drop of 0.25% trypsin/EDTA and replated into individual wells of 12-well plates on a
layer of irradiated MEF. For genotyping, MEF were removed from the cultures and
ES cells were passaged three times on gelatin-coated plates. ES cells were
maintained in DMEM (Gibco, Invitrogen, Carlsbad, CA, USA) with 20% FCS, non-
essential amino acids, 0.05mM 2-mercaptoethanol, 100U/ml penicillin, 0.1mg/ml
streptomycin and 1000U/ml murine LIF (Chemicon International, Temecula, CA,
USA) on a layer of irradiated or mitomycin C-treated MEF. For embryoid body
formation,10
3EScells/0.03mlLIF-freeculturemediumweresuspendedinhanging
drops and maintainedfor 2–3 days, and/or transferred to uncoated Petri dishes and
cultured in suspension in the same medium.
RNA and protein analysis. Total RNA was prepared from ES cell or whole
embryo lysates using Trizol (Invitrogen). RNA was analyzed by RT-PCR using
Superscript III (Invitrogen) according to standard procedures. Quantitative real-time
RT-PCR was performed using SYBR green and speciﬁc primers (sequences
available from the authors on request).
For western blot analysis of protein expression, embryos, ES cells or EB were
boiled in 2  sample buffer containing SDS and mercaptoethanol (Merck,
Darmstadt,Germany).Proteinextractswereclearedbycentrifugation,separatedby
SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose. Blot
membranes were blocked in Tris-buffered saline solution with Tween20-5% non-fat
drymilkandprobedwithanti-Dido3(generatedinourlab),-pRb(1:1000;9308,Cell
Signaling, Beverly, MA, USA), -Oct4 (1:200; sc-5279, Santa Cruz Biotechnology,
Santa Cruz, CA, USA), -Nanog (1:1000; AB9220, Chemicon International), -Sox2
(1:500; AB5603, Chemicon International) or -actin antibody (1:5000; AC-74,
Sigma, St Louis, MO, USA).
For immunoﬂuorescence, ES cells, cell explants from trypsin/EDTA-digested
(30–45min, 371C) embryos, whole embryos or EB were ﬁxed with 4%
paraformaldehyde in PBS, permeabilized with 1% Triton X-100 and stained with
antibodies to centrin1 (1:200; ab 11257, Abcam, Cambridge, UK), g-tubulin
(1:1000; T 6557, Sigma), g-H2AX (1:250; IHC-00059, Bethyl Laboratories,
Montgomery, TX, USA), Oct4 (1:50; Santa Cruz) or GATA-4 (1:40; AF2606, R&D
Systems, Minneapolis, MN, USA). ES cells and EB were stained for AP with the
StemTAG kit (Cell Biolabs, San Diego, CA, USA).
For whole-embryo analysis, uteruses were isolated at the indicated days post-
coitum, ﬁxed in 4% paraformaldehyde (4h), dehydrated, parafﬁn-embedded and
sectioned (0.05mm for hematoxylin/eosin (HE) staining or immunohistochemistry;
0.01mm for in situ hybridization). Sections were incubated on slides (371C,
overnight), deparafﬁnized, rehydrated and used for HE staining, immunohisto-
chemistry or in situ hybridization. For anti-BrdU-ﬂuorescein isothiocyanate labeling
of S-phase cells, pregnant females received an injection of BrdU (0.1mg/g body
weight) 1h before being killed, uteruses were removed and treated as above. We
detected apoptotic cells by the TUNEL assay using the In Situ Cell Death Detection
kit (Roche, Mannheim, Germany).
Dido3 expression constructs and transfection. For reconstitution
experiments, we cloned cDNA of full-length Dido3 and N-terminal truncated Dido3
into the pCAGGS mammalian expression vector in front of an internal ribosome
entry site and puromycin-resistance cassette. ES cells were transfected with
Lipofectamine 2000(Invitrogen)accordingto themanufacturer’sprotocol; 24h after
transfection, puromycin (1mg/ml) was added to culture medium and cells were
selected for puromycin resistance for at least 1week. Pooled colonies and/or single
colonies were picked, expanded and tested for overexpression of full-length Dido3
or DNTDido3.
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